Sartorius Stedim Biotech S.A. Current Cash

Sartorius Stedim Biotech S.A. (SRTOY) currently reports a current cash of $200M as of June 2026. That compares with $700M in the prior-year period — down 70.8% year over year. Use the charts on this page to explore Sartorius Stedim Biotech S.A.'s current cash history and peer comparisons.

Sartorius Stedim Biotech S.A.'s current cash decreased from $700M to $200M — a 70.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sartorius Stedim Biotech S.A. reported $200M in current cash as of June 2026. That compares with $700M in the prior-year period — down 70.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $200M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sartorius Stedim Biotech S.A., and consider following SRTOY for alerts when major investors trade the stock.